IO Biotech enrols 380 patients with advanced melanoma in phase 3 trial
13th November 2023 Uncategorised 0The trial is evaluating an investigational cancer vaccine in combination with Keytruda
More: IO Biotech enrols 380 patients with advanced melanoma in phase 3 trial
Source: News